MGAT5 expression levels, which have been shown to be driven by the oncogenic RAS-RAF-ETS1 pathway (Kang et al. 1996; Buckhaults et al. 1997), are elevated in various cancer types (Zhao et al. 2008a, 2008b). This evidence concerns the gene ETS1 and cancer.